- For US Healthcare Professionals Only
- Important Safety Information
- Full Prescribing Information
- INVEGA HAFYERA™ Consumer Site

Explore Your Patients’ Reasons for Wanting Just 2 Doses a Year
For adults currently treated with oral antipsychotics who may:
- Feel self-stigma from having to take daily medication for schizophrenia
- Want to feel less defined by their daily schizophrenia medication
- Struggle to stay on track with treatment goals, daily medication requirements, and other aspects of their treatment plan
For adults currently treated with INVEGA SUSTENNA® or INVEGA TRINZA® who:
- Like fewer doses a year for a life less defined by their schizophrenia treatment
- Like to work towards longer-term goals
- Benefit from more time between doses to focus on other aspects of their treatment
Keep Your Appointments, Deepen Your Conversations
With the twice-yearly dosing of INVEGA HAFYERA™, you can spend less time during monthly appointments discussing medication adherence and more time discussing your patients’ treatment goals, such as:

Relationships or social interactions

Activities of daily living

Diet/healthy choices

Smoking cessation

Metabolic/weight monitoring
See What 2 Doses Per Year Could Mean for Adult Patients With Schizophrenia
How Could a Twice-yearly Option Change Your Treatment Conversations?
If you and your adult patient are considering long-acting injectable antipsychotics for the first time, the eventual possibility of twice-yearly dosing may motivate them to transition to INVEGA SUSTENNA® (paliperidone palmitate).*
INVEGA HAFYERA™ is to be used only after adequate treatment has been established with INVEGA SUSTENNA® for at least 4 months (with the last 2 doses being 156 mg or 234 mg), or INVEGA TRINZA® for at least one 3-month injection cycle (at doses of 546 mg or 819 mg).1
Make a Plan for 2 Doses Per Year With INVEGA HAFYERA™
REFERENCE: 1. INVEGA HAFYERA™ [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; August 2021.